Professor of Medicine
McGill University
McGill University
Montreal, Quebec, Canada
Giada Sebastiani (MD FAASLD) is Professor of Medicine at McGill University (first woman with this academic rank in the Division of Gastroenterology and Hepatology at McGill University) and Clinician Scientist at the Research Institute of McGill University Health Centre in Montreal, Canada. She received a medical degree and specialized in internal medicine at the University of Padua, Italy. She trained in clinical and basic research at Harvard Medical School (US), University College of London (UK), University of Bordeaux (France) and Lady Davis Institute for Medical Research (Montreal, Canada).
Her work focuses on fatty liver disease, liver fibrosis and non-invasive diagnostic tools in liver disease, with a current focus on at-risk populations, including people with diabetes, people living with HIV, patients with inflammatory bowel diseases and women with polycystic ovary syndrome. She is author of 210 articles in peer-reviewed journals (including Lancet Gastroenterology and Hepatology, Nature Reviews Gastroenterology & Hepatology, Lancet Regional Health, Gastroenterology, Hepatology, Journal of Hepatology, Clinical Infectious Diseases; h-index=54), 14 book chapters, over 326 conference publications at national and international congresses. She is founding and steering committee member of the Canadian MASLD Network. She is Co-Chair of the first MASLD chapter in the Diabetes Canada guidelines and panel member of the first Canadian MASH guidance (2025). She is also panel member in the Consensus on Models of Care in fatty liver disease of the International Liver Foundation. Dr Sebastiani is one of two North American representatives in the guidelines of the prestigious European AIDS Clinical Society (primary reviewer of the liver section). Dr Sebastiani has been invited speaker in 80 international congresses and universities, including European, Asian Pacific, Mexican, Italian and Canadian Associations for the Study of the Liver. She was awarded the prestigious Merite Clinical Research Salary Award from Fonds Recherche Sante Quebec. Her research program is funded by the Canadian Institute for Health Research, the Fonds Recherche Sante Quebec, the CIHR Canadian HIV Trials Network, Crohn’s Colitis Canada.
Dr Sebastiani is President Elect of the Canadian Association for the Study of the Liver (2024-2026).
Disclosure(s): Abbvie: Speaker/Honoraria (Terminated, November 4, 2025); Canada Drug Agency: Consultant (Terminated, November 4, 2025); Canadian Institutes of Health Research (CIHR): Grant/Research Support (Ongoing); CCRN: Speaker/Honoraria (Ongoing); Crohn's and Colitis Canada: Grant/Research Support (Ongoing); Eli Lilly: Speaker/Honoraria (Ongoing); FRQS: Grant/Research Support (Ongoing); Gilead: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); GlaxoSmithKline (GSK): Advisory Board (Ongoing); Lupin: Speaker/Honoraria (Ongoing); Merck: Speaker/Honoraria (Ongoing); Montreal General Hospital Foundation: Grant/Research Support (Ongoing); Novo Nordisk Canada: Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing)
Saturday, November 29, 2025
09:15 - 10:30 Toronto